TAB2 Promotes Immune Escape and Chemoresistance Through NF ‐ κB Pathway Activation in Cervical Cancer
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70522 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Man Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Reproductive Medicine of Guangdong Province, Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: NF-kappa B, Uterine Cervical Neoplasms, Drug Resistance, Neoplasm, Adaptor Proteins, Signal Transducing. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cervical cancer (CC) remains a major health challenge with high mortality rates due to chemoresistance and immune escape. However, the underlying mechanisms remain unclear. We investigated the role of TAB2 in CC using cisplatin‐resistant and parental cell lines. Cell proliferation, migration, sphere formation and T cell‐mediated killing assays were performed. Western blot and qRT‐PCR analysed protein and mRNA expression. NF‐κB pathway involvement was examined using the BAY 11–7082 inhibitor. TAB2 expression was significantly elevated in cisplatin‐resistant CC cells. TAB2 overexpression promoted chemoresistance and immune escape through NF‐κB pathway activation. Conversely, TAB2 knockdown or NF‐κB inhibition sensitised resistant cells to cisplatin and enhanced T cell‐mediated killing. The resistant phenotype could be rescued by restoring PD‐L1 expression. Our findings reveal TAB2 as a critical regulator of both chemoresistance and immune escape in CC through NF‐κB pathway activation. This suggests TAB2 as a potential therapeutic target for overcoming treatment resistance in CC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Reproductive Medicine of Guangdong Province, Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
- Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guang…
- Department of Obstetrics and Gynecology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Guangdong Provincial Clinical Research Center for Obstetrical and Gynecological Diseases, Guangzhou, Guangdong, China.
ORCID-Profile: Yijia Zhou
Zitieren
APA
Wu, M., Zhang, Y., Wang, X., & Zhou, Y. (2025). TAB2 Promotes Immune Escape and Chemoresistance Through NF ‐ κB Pathway Activation in Cervical Cancer. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70522
Vancouver
Wu M, Zhang Y, Wang X, Zhou Y. TAB2 Promotes Immune Escape and Chemoresistance Through NF ‐ κB Pathway Activation in Cervical Cancer. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70522
BibTeX
@article{Wu2025,
author = {Wu, Man and Zhang, Yingying and Wang, Xuanhui and Zhou, Yijia},
title = {TAB2 Promotes Immune Escape and Chemoresistance Through NF ‐ κB Pathway Activation in Cervical Cancer},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70522}
}
EUVIMED